We are live on ! Find out more
Simplex Trading

Simplex Trading Portfolio holdings

AUM $149B
1-Year Est. Return 62.07%
 

Simplex Trading, founded in 2004 and headquartered in Chicago, Illinois, is a technology-driven proprietary trading firm specializing in market-making and liquidity provision, primarily in U.S. equity options and futures options. Leveraging advanced proprietary software and data-driven analysis, the firm optimizes trading strategies and develops innovative solutions to capitalize on financial market opportunities, maintaining a competitive edge through automation and a collaborative team of technologists and traders. With a workforce exceeding 300 and led by CEO Erik Swanson since 2014, Simplex operates with a low-ego, high-intelligence culture, focusing on minimal bureaucracy and rapid execution, while also making strategic venture capital investments in fintech startups. Recognized as a top workplace in Chicago by Built In’s 2025 awards, Simplex continues to evolve, blending cutting-edge technology with a commitment to market efficiency and growth.

This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+62.07%
3 Year Est. Return
+116.86%
5 Year Est. Return
+116.02%
10 Year Est. Return
+774.44%
AUM
$1.5B
AUM Growth
+$242M
Cap. Flow
+$178M
Cap. Flow %
11.93%
Top 10 Hldgs %
18.61%
Holding
7,153
New
1,586
Increased
2,321
Reduced
1,709
Closed
1,363

Sector Composition

Rank Sector Weight
1 Communication Services 6.61%
2 Healthcare 6.55%
3 Technology 6.45%
4 Consumer Discretionary 4.54%
5 Financials 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRI
5126
PUT
DELISTED
Albany Molecular Research Inc
AMRI
$2K ﹤0.01%
+19
New +$277
CCP
5127
CALL
DELISTED
Care Capital Properties, Inc.
CCP
$2K ﹤0.01%
+21
New +$550
CCP
5128
PUT
DELISTED
Care Capital Properties, Inc.
CCP
$2K ﹤0.01%
+46
New +$1.21K
JIVE
5129
PUT
DELISTED
Jive Software, Inc.
JIVE
$2K ﹤0.01%
18
WINT
5130
PUT
DELISTED
Windtree Therapeutics Inc
WINT
$2K ﹤0.01%
11
+1
+10% +$2
ZLTQ
5131
CALL
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$2K ﹤0.01%
+35
New +$984
VASC
5132
CALL
DELISTED
Vascular Solutions Inc
VASC
$2K ﹤0.01%
12
+1
+9% +$37
IQNT
5133
CALL
DELISTED
Inteliquent, Inc.
IQNT
$2K ﹤0.01%
+57
New +$964
PPS
5134
CALL
DELISTED
Post Properties
PPS
$2K ﹤0.01%
+10
New +$591
SAAS
5135
PUT
DELISTED
inContact, Inc.
SAAS
$2K ﹤0.01%
+10
New +$115
SGI
5136
PUT
DELISTED
Silicon Graphics Intl.
SGI
$2K ﹤0.01%
+11
New +$61
PTX
5137
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$2K ﹤0.01%
472
+262
+125% +$1.71K
SQNM
5138
DELISTED
SEQUENOM INC NEW
SQNM
$2K ﹤0.01%
+3,200
New +$3.82K
FNFG
5139
PUT
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$2K ﹤0.01%
54
-25
-32% -$257
EXAM
5140
CALL
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$2K ﹤0.01%
135
-19
-12% -$648
UNIS
5141
CALL
DELISTED
Unilife Corporation
UNIS
$2K ﹤0.01%
+27
New +$118
RVLT
5142
PUT
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$2K ﹤0.01%
+62
New +$374
IO
5143
PUT
DELISTED
ION Geophysical Corporation
IO
$2K ﹤0.01%
+20
New +$150
PKN
5144
PUT
DELISTED
POWERSHARES GLOBAL NUCLEAR ENERGY PORTFOLIO
PKN
$2K ﹤0.01%
+32
New +$2K
EEN
5145
CALL
DELISTED
CLAYMORE GUGGENHEIM EW EURO-PACIFIC LDRS ETF
EEN
$2K ﹤0.01%
27
-285
-91% -$21.1K
PGH
5146
PUT
DELISTED
Pengrowth Energy Corporation
PGH
$2K ﹤0.01%
+431
New +$701
HYGS
5147
DELISTED
Hydrogenics Corp
HYGS
$2K ﹤0.01%
+303
New +$2.43K
PDLI
5148
CALL
DELISTED
PDL BioPharma, Inc.
PDLI
$2K ﹤0.01%
230
+161
+233% +$537
RBS.PRX
5149
CALL
DELISTED
ROYAL BK SCOTLAND GRP"XCAPS"-A
RBS.PRX
$2K ﹤0.01%
304
-171
-36% -$1.13K
KNL
5150
DELISTED
Knoll, Inc.
KNL
$2K ﹤0.01%
118
-253
-68% -$5.93K

Similar funds

Simplex Trading's Q2 2016 Portfolio in Review

As of Q2 2016, Simplex Trading held 7,153 positions worth $1.5B, up 19% from $1.25B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Simplex Trading deployed $178M of net new capital in Q2 2016, opening 1,586 new positions and adding to 2,321 existing holdings. Its largest new stake was Biogen: 56,467 shares worth $13.7M.

By sector, the portfolio is most concentrated in Communication Services at 6.6% of assets, down from 6.9% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Broadcom, an estimated $36.7M trimmed.

  • Simplex Trading's largest Q2 2016 buy was Biogen: 56,467 shares worth $13.7M.
  • Simplex Trading added most to LinkedIn Corporation in Q2 2016, an estimated $21.4M increase.
  • Simplex Trading's biggest Q2 2016 reduction was Broadcom, cutting an estimated $36.7M.
  • Simplex Trading fully exited Alphabet (Google) Class C in Q2 2016, selling an estimated $20.1M.
  • Simplex Trading's ten largest holdings make up 19% of its $1.5B portfolio in Q2 2016.
  • Simplex Trading opened 1,586 new positions and closed 1,363 in Q2 2016.
  • Simplex Trading's portfolio value rose 19% quarter-over-quarter to $1.5B.

Based on Simplex Trading's 13F filing for Q2 2016, filed 18 Jul 2016.